UNSPSC 51182108: Desmopressin acetate

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H64N14O12S2.C2H4O2.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XB13HYU18U, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine- but more generally known as desmopressin acetate, which bears US NIH Compound Identifier 27991. European Medicines Agency schedules Desmopressin acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01597MIG.

UNSPSC 51182108 Desmopressin acetate is a Commodity code that covers the procurement of this synthetic vasopressin analog, a medication used to treat diabetes insipidus, nocturnal enuresis, and hemophilia A. State and local governments purchase desmopressin acetate primarily through their healthcare systems, correctional facilities, and public health departments for patient treatment and clinical management. The medication is procured in various formulations — intranasal spray, oral tablets, subcutaneous or intravenous injection — depending on clinical application and patient need. Buying entities include state Medicaid agencies, county health departments, municipal hospitals, state prison systems, and specialized health authorities responsible for inpatient and outpatient pharmaceutical supply chains.

The source provided contains no recent state or local contract opportunities tagged to this Commodity code, making it impossible to characterize current geographic activity, representative solicitations, or issuing-body patterns. State and local procurement of pharmaceutical products at the ingredient level typically occurs through established group purchasing organizations, state Medicaid formulary contracts, or prime vendor agreements rather than individual competitive bids; the absence of posted opportunities may reflect these standing contractual arrangements rather than lack of procurement activity.